Charcot-Leyden crystals in the trephine biopsy of a patient with a FIP1L1-PDGFRA– positive myeloproliferative disorder
Atypical presentation of varicella zoster in a patient on alemtuzumab
Light and shadows in the iron chelation treatment of haematological diseases
Management of cold haemolytic syndrome
Thrombosis and acute lymphoblastic leukaemia
Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK
Flow cytometric detection of circulating tumour cells in nucleophosmin/anaplastic lymphoma kinase-positive anaplastic large cell lymphoma
Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acid
MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas
In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle
Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma
Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas
A clinical score predicting a brief and uneventful course of newly diagnosed idiopathic trombocytopenic purpura in children
Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes
Microparticles adhere to collagen type I, fibrinogen, von Willebrand factor and surface immobilised platelets at physiological shear rates
ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis
Contribution of natural anticoagulant and fibrinolytic factors in modulating the clinical severity of haemophilia patients
Viscum album agglutinin-I induces degradation of cytoskeletal proteins in leukaemia PLB-985 cells differentiated toward neutrophils
Effect of haematological improvement on survival in patients given targeted therapy as initial treatment of acute myeloid leukaemia or high-risk myelodysplastic syndrome
Previous fetal loss significantly increases the risk of pre-partal deep-vein thrombosis
Could rhG-CSF induction of tetraploidy contribute to leukemogenesis in healthy donors?
The development of sarcoidosis with the use of alemtuzumab – clues to T-cell immune reconstitution